CastleArk Alternatives’s CareDx CDNA Stock Holding History

CastleArk Alternatives’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-71,720	Closed	-$4.54M	–	63
2021 Q3	$4.54M	Buy	+71,720	New	+$5.46M	0.17%	134

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

CastleArk Alternatives's CDNA Position: Q4 2021 in Review

CastleArk Alternatives sold out of CareDx (CDNA) in Q4 2021, closing a stake of 71,720 shares — an estimated $4.54M sold.

CastleArk Alternatives first reported a position in CDNA in Q3 2021 and held it in 1 quarter. The position peaked at $4.54M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

CastleArk Alternatives reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 71,720 CareDx shares in Q4 2021, an estimated $4.54M.
CastleArk Alternatives first reported a position in CareDx in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's CareDx position peaked at $4.54M in Q3 2021.
224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.